Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 23 2 2019
medline: 8 9 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

To investigate prospectively the association of body fat percentage (BF%) estimates using various equations from bioelectrical impedance analysis (BIA) with cardiovascular events, compared with body mass index (BMI) and waist circumference. We used data of 34 BIA-BF%-equations that were used for estimation of BF% in 6486 (men = 3194, women = 3294) subjects. During a median follow-up of 8.3 years, 510 (7.9%) cardiovascular events (363 in men; 147 in women) occurred. In men, the crude hazard ratio (95% confidence interval) for BF% from the best predicting BIA-BF%-equation was 3.97 (3.30-4.78) against 2.13 (1.85-2.45) for BF% from the BIA device's BIA-BF%-equation, 1.34 (1.20-1.49) for BMI and 1.49 (1.40-1.73) for waist circumference per log-1-SD increase of all. In women, the hazard ratios for best predicting BIA-BF%-equation, BIA device estimation, BMI and waist circumference were 3.80 (2.85-4.99), 1.89 (1.57-2.28), 1.35 (1.21-1.51) and 1.52 (1.31-1.75), respectively. After adjustments for age, Framingham cardiovascular disease risk score and creatinine excretion - a marker of muscle mass - BF%s and BMI remained independently associated with cardiovascular events in both men and women, while waist circumference was independently associated with cardiovascular events in men, but not in women. According to discrimination ability (C-index) and additive predictive value (net reclassification index and integrated discrimination index) on obesity measures to the Framingham cardiovascular disease risk score, BF% was superior to BMI and waist circumference in both men and women. BF% was independently associated with future cardiovascular events. Body fat estimates from the best-predicting BIA-BF%-equations can be a more predictive measurement in cardiovascular risk assessment than BMI or waist circumference.

Identifiants

pubmed: 30791699
doi: 10.1177/2047487319833283
pmc: PMC6545622
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-916

Commentaires et corrections

Type : CommentIn

Références

Nutrition. 2001 Jan;17(1):26-30
pubmed: 11165884
Am J Clin Nutr. 2003 Feb;77(2):379-84
pubmed: 12540397
Clin Nutr. 2004 Oct;23(5):1226-43
pubmed: 15380917
Circulation. 2006 Feb 14;113(6):791-8
pubmed: 16461820
Obesity (Silver Spring). 2006 Mar;14(3):480-90
pubmed: 16648620
Scand J Public Health. 2006;34(6):568-75
pubmed: 17132589
Obesity (Silver Spring). 2007 Mar;15(3):785-95
pubmed: 17372330
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):462-8
pubmed: 19185476
JAMA. 2009 May 6;301(17):1790-7
pubmed: 19417196
Atherosclerosis. 2009 Dec;207(2):534-40
pubmed: 19535078
Nutrition. 2010 Apr;26(4):382-9
pubmed: 19632090
Stat Med. 2013 Jun 30;32(14):2430-42
pubmed: 23037800
Eur J Clin Nutr. 2013 Jan;67 Suppl 1:S79-85
pubmed: 23299875
Eur J Clin Nutr. 2013 Oct;67(10):1081-6
pubmed: 23839666
Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1112-9
pubmed: 24932537
Am J Cardiol. 2016 Apr 15;117(8):1355-60
pubmed: 26949037
Circ Res. 2016 Apr 15;118(8):1273-93
pubmed: 27081110
Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96
pubmed: 27353126
Eur J Prev Cardiol. 2018 Mar;25(4):395-401
pubmed: 29319343
Eur J Prev Cardiol. 2018 Jul;25(10):1083-1086
pubmed: 29692207
Eur J Prev Cardiol. 2018 Dec;25(18):1977-1979
pubmed: 30348005
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Am J Clin Nutr. 1996 Sep;64(3 Suppl):436S-448S
pubmed: 8780360

Auteurs

Oyuntugs Byambasukh (O)

1 Department of Epidemiology, University Medical Centre Groningen, University of Groningen, The Netherlands.
2 Department of Internal Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.

Michele F Eisenga (MF)

3 Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, The Netherlands.

Ron T Gansevoort (RT)

3 Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, The Netherlands.

Stephan Jl Bakker (SJ)

3 Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, The Netherlands.

Eva Corpeleijn (E)

1 Department of Epidemiology, University Medical Centre Groningen, University of Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH